HALO logo
halo search icon
Theralase Technologies Inc.
Theralase Technologies Inc.
TLT · TSX

Theralase Technologies Inc.

CA$0.24

Price Arrow0.02 (9.09%)
20/05/2026 12:00:00 AM
All-CompaniesAll-ConsensusBig CandleEMA 125 BreakdownFakey Shakey - LongHALO AllRecent Earnings upgradeVolume Spike
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Theralase Technologies Inc. Overview

TLT Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Strong

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About TLT

icon

Website

Theralase Technologies Inc.

icon

Telephone

1.416.699.5273

icon

Address

41 Hollinger Road, Toronto, ON M4B 3G4

Description

Theralase Technologies, Inc. engages in the design, development, and manufacture of patented laser technology platforms used in bio-stimulative and bio-destructive clinical applications in patients. It operates through the Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT) segments. The ACT segment covers the research and development of photo dynamic compounds (PDCs) for the treatment of cancer. The CLT segment is responsible for the company’s medical laser business, which researches, develops, manufactures, and distributes CLT systems to healthcare practitioners predominantly for the healing of pain. The company was founded by Roger J. Dumoulin-White on August 22, 1989 and is headquartered in Toronto, Canada.

TLT Price Chart

Key Stats

Market Cap

CA$61.69M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.14 - 0.41

Trade Value (12mth)

US$7,805.00

1 week

4.35%

1 month

-28.36%

YTD

33.33%

1 year

41.18%

All time high

1.39

Key Fundamentals

EPS 3 yr Growth

-35.30%

EBITDA Margin

-478.90%

Operating Cashflow

-$3m

Free Cash Flow Return

-159.00%

ROIC

-199.40%

Interest Coverage

-92.90

Quick Ratio

0.90

Other Data

Shares Outstanding (Fully Diluted)

265m

HALO Sector

Healthcare

Next Company Report Date

28-Apr-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

CAD

Short Sell (% of issue)

0.00

TLT Fundamentals

Per Share Records

Historical data

Forecast data

CAD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-0.02-0.02-0.02locklocklock
EPS (Fully Diluted)
$locklocklocklock-0.02-0.02-0.02locklocklock
Growth
%locklocklocklock17.514.97.9locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Theralase Technologies Inc. (TLT:TSX)?
Halo FAQ
The current share price of Theralase Technologies Inc. (TLT:TSX) is CAD$0.24.
What is the 52-week high share price for Theralase Technologies Inc. (TLT:TSX)?
Halo FAQ
The 52-week high share price for Theralase Technologies Inc. (TLT:TSX) is CAD$0.41.
What is the 52-week low share price for Theralase Technologies Inc. (TLT:TSX)?
Halo FAQ
The 52-week low share price for Theralase Technologies Inc. (TLT:TSX) is CAD$0.14.
What is the dividend yield for Theralase Technologies Inc. (TLT:TSX)?
Halo FAQ
Theralase Technologies Inc. (TLT:TSX) does not pay a dividend.
What was Theralase Technologies Inc. (TLT:TSX) last dividend payment?
Halo FAQ
Theralase Technologies Inc. (TLT:TSX) does not pay a dividend.
What is the franking level for Theralase Technologies Inc. (TLT:TSX)?
Halo FAQ
Theralase Technologies Inc. (TLT:TSX) has a franking level of 0.00%.
In which sector is Theralase Technologies Inc. (TLT:TSX) classified?
Halo FAQ
Theralase Technologies Inc. (TLT:TSX) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.